DexCom, Inc.
DXCM
$72.77
-$5.07-6.51%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 151.70M | 134.60M | 143.50M | 146.40M | 256.30M |
Total Depreciation and Amortization | 74.50M | 55.30M | 52.10M | 52.50M | 69.00M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 68.80M | -6.20M | 16.20M | -8.70M | 66.40M |
Change in Net Operating Assets | 6.40M | 15.80M | 67.60M | 19.00M | -258.10M |
Cash from Operations | 301.40M | 199.50M | 279.40M | 209.20M | 133.60M |
Capital Expenditure | -124.60M | -111.20M | -66.10M | -56.90M | -52.50M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -179.10M | 321.50M | -122.80M | 131.70M | 467.40M |
Cash from Investing | -303.70M | 210.30M | -188.90M | 74.80M | 414.90M |
Total Debt Issued | -- | -- | -- | -- | 0.00 |
Total Debt Repaid | -- | -- | -- | -- | -136.80M |
Issuance of Common Stock | 0.00 | 14.80M | 0.00 | 13.40M | 0.00 |
Repurchase of Common Stock | 0.00 | -750.00M | -- | -- | -500.00M |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -1.60M | -1.30M | -1.40M | -8.70M | 4.90M |
Cash from Financing | -1.60M | -736.50M | -1.40M | 4.70M | -631.90M |
Foreign Exchange rate Adjustments | -11.20M | 8.60M | -1.00M | -3.80M | 6.10M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -15.10M | -318.10M | 88.10M | 284.90M | -77.30M |